{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:39:41Z","timestamp":1780922381322,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.7759\/cureus.95108","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:34:31Z","timestamp":1761104071000},"source":"Crossref","is-referenced-by-count":2,"title":["Primary Central Nervous System (CNS) Post-Transplant Lymphoproliferative Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Jared M","family":"Taitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos G","year":"1995","unstructured":"Mosialos G, Birkenbacht M, Yalamanchill R, et al.. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 1995, 80:389-399. 10.1016\/0092-8674(95)90489-1","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0726-6","article-title":"Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential","volume":"10","author":"White ML","year":"2019","unstructured":"White ML, Moore DW, Zhang Y, et al.. Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential. Insights Imaging. 2019, 10:46. 10.1186\/s13244-019-0726-6","journal-title":"Insights Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24834","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report","volume":"116","author":"Cavaliere R","year":"2010","unstructured":"Cavaliere R, Petroni G, Lopes MB, Schiff D. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer. 2010, 116:863-70. 10.1002\/cncr.24834","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12211","article-title":"Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era","volume":"13","author":"Evens AM","year":"2013","unstructured":"Evens AM, Choquet S, Kroll-Desrosiers AR, et al.. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant. 2013, 13:1512-22. 10.1111\/ajt.12211","journal-title":"Am J Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-112184","article-title":"Dose-adjusted Teddi-R induces durable complete remissions in relapsed and refractory primary CNS lymphoma","volume":"132","author":"Roschewski M","year":"2018","unstructured":"Roschewski M, Lionakis MS, Melani C, et al.. Dose-adjusted Teddi-R induces durable complete remissions in relapsed and refractory primary CNS lymphoma. Blood. 2018, 132:4195-4195. 10.1182\/blood-2018-99-112184","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-making progress when most needed","volume":"21","author":"Poggio ED","year":"2021","unstructured":"Poggio ED, Augustine JJ, Arrigain S, et al.. Long-term kidney transplant graft survival-making progress when most needed. Am J Transplant. 2021, 21:2824-32. 10.1111\/ajt.16463","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000079253.06061.52","article-title":"Primary brain lymphomas after kidney transplantation: presentation and outcome","volume":"76","author":"Snanoudj R","year":"2003","unstructured":"Snanoudj R, Durrbach A, Leblond V, et al.. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation. 2003, 76:930-7. 10.1097\/01.TP.0000079253.06061.52","journal-title":"Transplantation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-004","article-title":"EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil","volume":"9","author":"O'Neill BP","year":"2007","unstructured":"O'Neill BP, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol. 2007, 9:364-9. 10.1215\/15228517-2007-004","journal-title":"Neuro Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15274\/NRJ-2014-10036","article-title":"The etiology of ring lesions on diffusion-weighted imaging","volume":"27","author":"Finelli PF","year":"2014","unstructured":"Finelli PF, Foxman EB. The etiology of ring lesions on diffusion-weighted imaging. Neuroradiol J. 2014, 27:280-7. 10.15274\/NRJ-2014-10036","journal-title":"Neuroradiol J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-011-0951-3","article-title":"Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder","volume":"94","author":"Shimizu H","year":"2011","unstructured":"Shimizu H, Saitoh T, Koya H, et al.. Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder. Int J Hematol. 2011, 94:495-8. 10.1007\/s12185-011-0951-3","journal-title":"Int J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and treatment of primary CNS lymphoma","volume":"9","author":"Korfel A","year":"2013","unstructured":"Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013, 9:317-27. 10.1038\/nrneurol.2013.83","journal-title":"Nat Rev Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000203554.54242.56","article-title":"Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis","volume":"81","author":"Caillard S","year":"2006","unstructured":"Caillard S, Agodoa LY, Bohen EM, Abbott KC. Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation. 2006, 81:888-95. 10.1097\/01.tp.0000203554.54242.56","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2003.00518.x","article-title":"WHO classification of tumours: pathology and genetics. Tumours of haematopoietic and lymphoid tissues","volume":"25","author":"Bentley S","year":"2003","unstructured":"Bentley S. WHO classification of tumours: pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Clin Lab Hae. 2003, 25:201-201. 10.1046\/j.1365-2257.2003.00518.x","journal-title":"Clin Lab Hae"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03594.x","article-title":"Immunotherapy for post-transplant lymphoproliferative disease","volume":"118","author":"Straathof KC","year":"2002","unstructured":"Straathof KC, Savoldo B, Heslop HE, Rooney CM. Immunotherapy for post-transplant lymphoproliferative disease. Br J Haematol. 2002, 118:728-40. 10.1046\/j.1365-2141.2002.03594.x","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai DE","year":"2001","unstructured":"Tsai DE, Hardy CL, Tomaszewski JE, et al.. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation. 2001, 71:1076-88. 10.1097\/00007890-200104270-00012","journal-title":"Transplantation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01211.x","article-title":"Treatment of PTLD with rituximab or chemotherapy","volume":"6","author":"Elstrom RL","year":"2006","unstructured":"Elstrom RL, Andreadis C, Aqui NA, et al.. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant. 2006, 6:569-76. 10.1111\/j.1600-6143.2005.01211.x","journal-title":"Am J Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)02058-9","article-title":"Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation","volume":"354","author":"Cook RC","year":"1999","unstructured":"Cook RC, Connors JM, Gascoyne RD, et al.. Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet. 1999, 354:1698-1699. 10.1016\/s0140-6736(99)02058-9","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06228.x","article-title":"Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen","volume":"134","author":"Fohrer C","year":"2006","unstructured":"Fohrer C, Caillard S, Koumarianou A, et al.. Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen. Br J Haematol. 2006, 134:602-12. 10.1111\/j.1365-2141.2006.06228.x","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.07.008","article-title":"Central nervous system post-transplant lymphoproliferative disorder: response to ibrutinib","volume":"20","author":"Kallam A","year":"2020","unstructured":"Kallam A, Hansen N, Bierman P. Central nervous system post-transplant lymphoproliferative disorder: response to ibrutinib. Clin Lymphoma Myeloma Leuk. 2020, 20:e930-3. 10.1016\/j.clml.2020.07.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.1078","article-title":"Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review","volume":"6","author":"Zheng P","year":"2025","unstructured":"Zheng P, Xu T, Zuo X, et al.. Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review. EJHaem. 2025, 6:e1078. 10.1002\/jha2.1078","journal-title":"EJHaem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376228-primary-central-nervous-system-cns-post-transplant-lymphoproliferative-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:34:35Z","timestamp":1761104075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376228-primary-central-nervous-system-cns-post-transplant-lymphoproliferative-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.95108","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}